Gentaur Donanemab – Anti-APP Antibody

Targets amyloid precursor protein (APP), used in Alzheimer’s disease research, amyloid clearance, and neurodegeneration assays.

This combination does not exist.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days